
NeoCura is a high-tech enterprise focused on developing innovative drugs using an AI-powered RNA technology platform. The company has established multi-omics big data acquisition platforms and bioomics databases, leveraging AI and bioinformatics for drug target mining and automated drug design. NeoCura operates R&D and production centers in Beijing, Shenzhen, and Guangzhou to support its pipeline development and clinical needs. Their R&D efforts span cancer vaccines, tumor immunomodulators, and virus vaccines, with over 10 first-in-class pipelines. The company emphasizes team advantages, bringing together experts in tumor immunology, RNA delivery, molecular engineering, AI, and industrialization, as well as resource integration across research, industry, and clinical fields.

NeoCura is a high-tech enterprise focused on developing innovative drugs using an AI-powered RNA technology platform. The company has established multi-omics big data acquisition platforms and bioomics databases, leveraging AI and bioinformatics for drug target mining and automated drug design. NeoCura operates R&D and production centers in Beijing, Shenzhen, and Guangzhou to support its pipeline development and clinical needs. Their R&D efforts span cancer vaccines, tumor immunomodulators, and virus vaccines, with over 10 first-in-class pipelines. The company emphasizes team advantages, bringing together experts in tumor immunology, RNA delivery, molecular engineering, AI, and industrialization, as well as resource integration across research, industry, and clinical fields.